Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1993-7-23
|
pubmed:abstractText |
A 27-base pair triplex forming oligonucleotide (G27-oligonucleotide) targeted to the "puf" regulatory protein-binding domain of the human c-myc oncogene has been conjugated with the DNA-binding molecule acridine (G27-conjugate) in order to obtain a drug with high binding affinity as well as high sequence specificity. Both the triplex-forming oligonucleotide and its acridine conjugate are shown to form triple-stranded DNA at the site of the target sequence by DNase 1 footprinting. When the cervical carcinoma cell line HeLa was exposed to 4 microM concentrations of the G27-oligonucleotide the viable cell count fell to 89, 56, and 49% of control at 25, 50, and 72 hr. After exposure to 1 microM G27-conjugate the viable cell count fell to 87, 50, and 33% of control. Nonspecific reductions in cell number were found for the control oligonucleotides to 79 and 82% of control. When SKOV-3 cells were exposed to the same concentrations of oligonucleotides, viable cell count in relation to control fell to 43, 50, and 67% with the G27-oligonucleotide and 57, 52, and 53% with the G27-conjugate at 24, 48, and 72 hr. The control oligonucleotides again caused a small nonspecific drop in the viable cell number.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acridines,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxyribonuclease I,
http://linkedlifedata.com/resource/pubmed/chemical/Oligonucleotides
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0090-8258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
49
|
pubmed:geneSymbol |
c-myc
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
339-43
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8314536-Acridines,
pubmed-meshheading:8314536-Antineoplastic Agents,
pubmed-meshheading:8314536-Base Sequence,
pubmed-meshheading:8314536-DNA, Neoplasm,
pubmed-meshheading:8314536-Deoxyribonuclease I,
pubmed-meshheading:8314536-Female,
pubmed-meshheading:8314536-Genes, myc,
pubmed-meshheading:8314536-HeLa Cells,
pubmed-meshheading:8314536-Humans,
pubmed-meshheading:8314536-Molecular Sequence Data,
pubmed-meshheading:8314536-Oligonucleotides,
pubmed-meshheading:8314536-Ovarian Neoplasms,
pubmed-meshheading:8314536-Tumor Cells, Cultured,
pubmed-meshheading:8314536-Uterine Cervical Neoplasms
|
pubmed:year |
1993
|
pubmed:articleTitle |
A unique c-myc-targeted triplex-forming oligonucleotide inhibits the growth of ovarian and cervical carcinomas in vitro.
|
pubmed:affiliation |
Division of Gynecologic Oncology, University of Alabama, Birmingham 35294.
|
pubmed:publicationType |
Journal Article
|